|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,380,000 |
Market
Cap: |
200.70(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$11.6 - $15.03 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 16.2 |
Insider 3/6 Months : 16.8 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Merrimack Pharmaceuticals is a biopharmaceutical company. Co. does not have any ongoing research or development activities.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
278,500 |
504,050 |
1,194,261 |
Total Buy Value |
$0 |
$3,532,303 |
$6,240,948 |
$13,669,512 |
Total People Bought |
0 |
1 |
2 |
4 |
Total Buy Transactions |
0 |
9 |
13 |
46 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-08-13 |
4 |
B |
$3.50 |
$2,132 |
I/I |
609 |
820,055 |
0.01 |
98% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-08-12 |
4 |
B |
$3.49 |
$6,986 |
I/I |
2,000 |
243,212 |
0.01 |
108% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-08-12 |
4 |
B |
$3.49 |
$6,986 |
I/I |
2,000 |
587,205 |
0.01 |
108% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-08-11 |
4 |
B |
$3.45 |
$48,437 |
I/I |
14,030 |
241,212 |
0.01 |
108% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-08-11 |
4 |
B |
$3.45 |
$48,480 |
I/I |
14,042 |
586,371 |
0.01 |
108% |
|
Crocker Gary L |
See Remarks |
|
2020-07-22 |
4 |
S |
$3.04 |
$233,562 |
I/I |
(75,546) |
0 |
|
-98% |
|
Crocker Gary L |
See Remarks |
|
2020-07-22 |
4 |
S |
$3.04 |
$362,903 |
D/D |
(117,963) |
0 |
|
-98% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-07-22 |
4 |
B |
$3.04 |
$552,087 |
I/I |
177,274 |
580,515 |
0.01 |
98% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-07-22 |
4 |
B |
$3.04 |
$552,086 |
I/I |
177,274 |
227,182 |
0.01 |
98% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-04-21 |
4 |
B |
$3.25 |
$4,628 |
I/I |
1,424 |
506,592 |
0.01 |
23% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-04-21 |
4 |
B |
$3.25 |
$4,628 |
I/I |
1,424 |
692,768 |
0.01 |
23% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-04-20 |
4 |
B |
$3.25 |
$7,556 |
I/I |
2,325 |
506,001 |
0.01 |
28% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-04-20 |
4 |
B |
$3.25 |
$7,556 |
I/I |
2,325 |
691,344 |
0.01 |
28% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-04-07 |
4 |
B |
$3.03 |
$17,885 |
I/I |
5,899 |
505,036 |
0.01 |
20% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-04-07 |
4 |
B |
$3.03 |
$17,885 |
I/I |
5,899 |
689,019 |
0.01 |
20% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-04-06 |
4 |
B |
$3.00 |
$18,108 |
I/I |
6,043 |
683,120 |
0.01 |
35% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-04-06 |
4 |
B |
$3.00 |
$18,105 |
I/I |
6,042 |
502,588 |
0.01 |
35% |
|
Western Standard Partners Qp, L.p. |
See Remarks |
|
2020-04-03 |
4 |
B |
$2.60 |
$27,924 |
I/I |
10,750 |
677,077 |
0.01 |
50% |
|
Ledo Capital, Llc |
See Remarks |
|
2020-04-03 |
4 |
B |
$2.59 |
$27,877 |
I/I |
10,750 |
500,081 |
0.01 |
50% |
|
Ledo Capital, Llc |
|
|
2019-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,173,166 |
|
- |
|
Western Standard Partners Qp, L.p. |
|
|
2019-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
842,913 |
|
- |
|
22nw Gp, Inc. |
10% Owner |
|
2019-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,241,896 |
|
- |
|
Aryeh Jason |
See Explanation of Responses |
|
2019-07-16 |
4 |
B |
$5.44 |
$1,643 |
D/D |
302 |
3,802 |
2.37 |
- |
|
Aryeh Jason |
See Explanation of Responses |
|
2019-07-12 |
4 |
B |
$5.62 |
$19,324 |
D/D |
3,400 |
3,500 |
2.37 |
- |
|
Aryeh Jason |
See Explanation of Responses |
|
2019-07-11 |
4 |
B |
$5.71 |
$571 |
D/D |
100 |
100 |
2.37 |
- |
|
324 Records found
|
|
Page 5 of 13 |
|
|